tetano
Editor, Senior Moderator
Lancet Respir Med. 2020 Apr 6. pii: S2213-2600(20)30161-2. doi: 10.1016/S2213-2600(20)30161-2. [Epub ahead of print]
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.
Phua J[SUP]1[/SUP], Weng L[SUP]2[/SUP], Ling L[SUP]3[/SUP], Egi M[SUP]4[/SUP], Lim CM[SUP]5[/SUP], Divatia JV[SUP]6[/SUP], Shrestha BR[SUP]7[/SUP], Arabi YM[SUP]8[/SUP], Ng J[SUP]9[/SUP], Gomersall CD[SUP]3[/SUP], Nishimura M[SUP]10[/SUP], Koh Y[SUP]5[/SUP], Du B[SUP]2[/SUP]; Asian Critical Care Clinical Trials Group.
Author information
Abstract
As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive care unit (ICU) community must prepare for the challenges associated with this pandemic. Streamlining of workflows for rapid diagnosis and isolation, clinical management, and infection prevention will matter not only to patients with COVID-19, but also to health-care workers and other patients who are at risk from nosocomial transmission. Management of acute respiratory failure and haemodynamics is key. ICU practitioners, hospital administrators, governments, and policy makers must prepare for a substantial increase in critical care bed capacity, with a focus not just on infrastructure and supplies, but also on staff management. Critical care triage to allow the rationing of scarce ICU resources might be needed. Researchers must address unanswered questions, including the role of repurposed and experimental therapies. Collaboration at the local, regional, national, and international level offers the best chance of survival for the critically ill.
Copyright ? 2020 Elsevier Ltd. All rights reserved.
PMID:32272080DOI:10.1016/S2213-2600(20)30161-2
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.
Phua J[SUP]1[/SUP], Weng L[SUP]2[/SUP], Ling L[SUP]3[/SUP], Egi M[SUP]4[/SUP], Lim CM[SUP]5[/SUP], Divatia JV[SUP]6[/SUP], Shrestha BR[SUP]7[/SUP], Arabi YM[SUP]8[/SUP], Ng J[SUP]9[/SUP], Gomersall CD[SUP]3[/SUP], Nishimura M[SUP]10[/SUP], Koh Y[SUP]5[/SUP], Du B[SUP]2[/SUP]; Asian Critical Care Clinical Trials Group.
Author information
Abstract
As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive care unit (ICU) community must prepare for the challenges associated with this pandemic. Streamlining of workflows for rapid diagnosis and isolation, clinical management, and infection prevention will matter not only to patients with COVID-19, but also to health-care workers and other patients who are at risk from nosocomial transmission. Management of acute respiratory failure and haemodynamics is key. ICU practitioners, hospital administrators, governments, and policy makers must prepare for a substantial increase in critical care bed capacity, with a focus not just on infrastructure and supplies, but also on staff management. Critical care triage to allow the rationing of scarce ICU resources might be needed. Researchers must address unanswered questions, including the role of repurposed and experimental therapies. Collaboration at the local, regional, national, and international level offers the best chance of survival for the critically ill.
Copyright ? 2020 Elsevier Ltd. All rights reserved.
PMID:32272080DOI:10.1016/S2213-2600(20)30161-2